Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:


Generated: April 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074912

« Back to Dashboard

NDA 074912 describes SELEGILINE HYDROCHLORIDE, which is a drug marketed by Apotex, Dava Pharms Inc, Lannett Co Inc, Apotex Inc, Boscogen, Chartwell Molecules, G And W Labs Inc, Mylan, Siegfried, and Somerset, and is included in thirteen NDAs. It is available from seven suppliers. Additional details are available on the SELEGILINE HYDROCHLORIDE profile page.

The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
Summary for 074912
Ingredient:selegiline hydrochloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 074912
Suppliers and Packaging for NDA: 074912
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074912 ANDA Mayne Pharma 51862-146 51862-146-06 60 TABLET in 1 BOTTLE (51862-146-06)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Apr 30, 1998TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.